Does Effective Management of Sleep Disorders Reduce Substance Dependence?

  • PDF / 140,991 Bytes
  • 11 Pages / 504.57 x 720 pts Page_size
  • 89 Downloads / 209 Views

DOWNLOAD

REPORT


REVIEW ARTICLE

ยช 2009 Adis Data Information BV. All rights reserved.

Does Effective Management of Sleep Disorders Reduce Substance Dependence? Thomas Roth, on behalf of the workshop participants Sleep Disorders and Research Center, Henry Ford Health System, Detroit, Michigan, USA

Abstract

Insomnia is often associated with substance dependence, with evidence suggesting that individuals seeking medical attention for sleep complaints are more likely to have drug or alcohol abuse problems than the general population. Disturbed sleep is associated with the abuse of a variety of drugs, with patients dependent on nicotine, alcohol and illicit drugs all reporting poor sleep. In addition, withdrawal from nicotine, alcohol and drugs of abuse is also associated with insomnia, and this may result in an increased risk of relapse if the sleep problems remain unresolved. Although studies suggest that the majority of pharmacological and behavioural interventions for insomnia are effective in treating sleep disturbances in dependent patients undergoing short-term drug withdrawal and short and long-term alcohol withdrawal, several questions remain unanswered. For example, little is known about the risk of relapse in abstinent drug-dependent patients experiencing withdrawal-related insomnia, the effect of insomnia treatment on nicotine withdrawal, or whether insomnia interventions prevent relapse. Participants of a workshop, held at the 6th annual meeting of The International Sleep Disorders Forum: The Art of Good Sleep in 2008, evaluated whether the effective management of sleep disorders could reduce substance dependence and the risk of relapse. Following the workshop a targeted literature review was conducted addressing this question. Data from this review that either pharmacological or cognitive behavioural treatment of insomnia could reduce the risk of relapse in substance dependence were substantially lacking. Further research is therefore required to increase our understanding of the impact of insomnia on patients with substance dependence.

Insomnia is defined as a symptom of difficulty falling asleep, frequent awakenings, awakening in the early morning and feeling unrefreshed upon wakening. The diagnostic criteria (Diagnostic and Statistical Manual of Mental Disorders, version IV) also require that the night-time sleep problem is associated with clinically significant daytime impairment or distress.[1] Typically, insomnia is associated with co-morbid conditions, such as psychiatric or medical disorders (depression, anxiety,

chronic pain, asthma), specific sleep disorders (restless legs syndrome, periodic limb movement disorder, sleep apnoea) and substance dependence (alcoholism, smoking, medication abuse, illicit drug use).[2] Indeed, evidence suggests that patients seeking medical attention for sleep complaints have a greater likelihood of drug and alcohol problems compared with the general population.[3] Individuals exhibiting substance dependence experience a variety of sleep disturbances. Studies

Roth

66

have re